Amphastar Pharmaceuticals Goodwill and Intangible Assets 2012-2024 | AMPH
Amphastar Pharmaceuticals goodwill and intangible assets from 2012 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Amphastar Pharmaceuticals Annual Goodwill and Intangible Assets
(Millions of US $) |
| 2023 |
$613 |
| 2022 |
$37 |
| 2021 |
$39 |
| 2020 |
$41 |
| 2019 |
$41 |
| 2018 |
$42 |
| 2017 |
$45 |
| 2016 |
$50 |
| 2015 |
$40 |
| 2014 |
$43 |
| 2013 |
$40 |
| 2012 |
$42 |
| 2011 |
$0 |
| 2009 |
$ |
Amphastar Pharmaceuticals Quarterly Goodwill and Intangible Assets
(Millions of US $) |
| 2024-09-30 |
$595 |
| 2024-06-30 |
$601 |
| 2024-03-31 |
$607 |
| 2023-12-31 |
$613 |
| 2023-09-30 |
$619 |
| 2023-06-30 |
$626 |
| 2023-03-31 |
$37 |
| 2022-12-31 |
$37 |
| 2022-09-30 |
$37 |
| 2022-06-30 |
$38 |
| 2022-03-31 |
$38 |
| 2021-12-31 |
$39 |
| 2021-09-30 |
$39 |
| 2021-06-30 |
$40 |
| 2021-03-31 |
$40 |
| 2020-12-31 |
$41 |
| 2020-09-30 |
$40 |
| 2020-06-30 |
$40 |
| 2020-03-31 |
$40 |
| 2019-12-31 |
$41 |
| 2019-09-30 |
$41 |
| 2019-06-30 |
$42 |
| 2019-03-31 |
$42 |
| 2018-12-31 |
$42 |
| 2018-09-30 |
$43 |
| 2018-06-30 |
$43 |
| 2018-03-31 |
$45 |
| 2017-12-31 |
$45 |
| 2017-09-30 |
$46 |
| 2017-06-30 |
$46 |
| 2017-03-31 |
$46 |
| 2016-12-31 |
$50 |
| 2016-09-30 |
$52 |
| 2016-06-30 |
$43 |
| 2016-03-31 |
$44 |
| 2015-12-31 |
$40 |
| 2015-09-30 |
$40 |
| 2015-06-30 |
$41 |
| 2015-03-31 |
$41 |
| 2014-12-31 |
$43 |
| 2014-09-30 |
$43 |
| 2014-06-30 |
$39 |
| 2014-03-31 |
$40 |
| 2013-12-31 |
$40 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
$42 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.142B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
